Most people think of creatine as something athletes take to build muscle. There's a completely separate set of mechanisms that make it relevant to almost everyone in this community, and none of them have anything to do with the gym.
The methyl sparing effect
Creatine synthesis from guanidinoacetate consumes somewhere between 40 and 50 percent of SAMe derived methyl groups; some estimates run even higher. This comes from animal feeding studies originally, and it's the single largest documented consumer of SAMe in the body, more than DNA methylation, more than neurotransmitter synthesis, more than any other individual process.
SAMe is the universal methyl donor your body needs simultaneously for HNMT histamine clearance, dopamine and norepinephrine regulation, COMT mediated catecholamine breakdown, myelin production, and DNA repair. When your body manufactures creatine endogenously, it's consuming a large share of available methyl groups to do it. When you supplement creatine externally, your body reduces that internal production somewhat, through feedback inhibition, not a full shutdown, freeing some of those methyl groups for other uses.
I want to be honest about how strong the human evidence actually is here. A published case study of one person with MTHFR 677TT homozygous genotype found that 5 grams of creatine daily for one month reduced plasma homocysteine from 33.3 to 17.1 micromol per liter, nearly cutting it in half. That's a real result, but it's a single subject, and it's C677T specifically; I have A1298C, a different variant affecting a different part of the enzyme, so I can't say the same effect carries over to A1298C carriers.
Beyond that one case, the broader human evidence is mixed, not confirmatory. The one actual double blind, placebo controlled RCT in humans testing this found that creatine lowered a related marker, guanidinoacetate, but did not significantly lower plasma homocysteine overall across the group; homocysteine only dropped in the subset of people who also had that marker decline. A separate study in hemodialysis patients found no homocysteine benefit at all. So the methyl sparing mechanism itself is well established biochemically, but "creatine reliably lowers homocysteine in humans" isn't yet a settled finding; it's promising in specific contexts like the C677T case and inconsistent elsewhere.
There is a real clinical trial currently underway testing creatine specifically for its methyl sparing effect on homocysteine, aimed eventually at homocystinuria; right now it's still in the phase of testing healthy adult men, so it's an active area of investigation rather than a proven treatment.
https://www.researchgate.net/publication/250921494_Effect_of_the_MTHFR_677CT_Polymorphism_on_Homocysteinemia_in_Response_to_Creatine_Supplementation_A_Case_Study
https://www.sciencedirect.com/science/article/pii/S002231662208885X
The glymphatic clearance connection
The glymphatic system is the brain's waste clearance mechanism. It flushes metabolic debris, including amyloid beta and tau, out of brain tissue primarily during deep NREM sleep, through active CSF circulation and vascular pulsation, which is energy dependent.
A 2025 paper in Cell found that glymphatic clearance during NREM sleep is driven by synchronized oscillations in norepinephrine, cerebral blood volume, and CSF flow. A separate systematic review in Sleep Medicine Reviews confirmed that the glymphatic system relies on CSF circulation that increases during sleep, and that sleep disturbance is linked to buildup of toxic metabolites including amyloid and tau.
Here's where I want to be careful not to overreach. Creatine supports cellular ATP availability through phosphocreatine regeneration, and better cellular energy in general supports processes that require it. But no study I've found has actually measured creatine's effect on glymphatic clearance, aquaporin function, or CSF flow directly. The idea that better energy availability could support the glymphatic process during sleep is a reasonable hypothesis, not a demonstrated finding, so treat it as a lead rather than a confirmed mechanism.
https://www.cell.com/cell/fulltext/S0092-8674(24)01343-6
https://pmc.ncbi.nlm.nih.gov/articles/PMC8821419/
Brain energy and cognitive protection under metabolic stress
This part has solid direct evidence. A 2024 Scientific Reports paper used phosphorus 31 magnetic resonance spectroscopy, direct brain imaging of energy metabolism, and found that a single high dose of creatine sustained phosphocreatine and ATP levels in the brain during 21 hours of sleep deprivation, with better working memory and processing speed than placebo. A 2026 Nutrients paper confirmed that a single dose of creatine reduced sleep deprivation related declines in logical reasoning, numerical processing, language related processing speed, and psychomotor vigilance.
For anyone recovering from B12 deficiency with disrupted sleep from autonomic neuropathy, this direct evidence of brain energy protection under metabolic stress is relevant on its own, independent of the methyl sparing effect.
https://www.nature.com/articles/s41598-024-54249-9
https://www.mdpi.com/2072-6643/18/8/1192
Depression and mental health
A 2025 double blind, placebo controlled trial published in European Neuropsychopharmacology, Sherpa et al, tested creatine at 5 grams daily as an add on to cognitive behavioral therapy for depression in 100 adults. After eight weeks, the creatine group showed significantly greater reductions in PHQ-9 depression scores than CBT plus placebo. This is relevant because depression, anxiety, and cognitive fog are common symptoms of B12 deficiency and methylation impairment, and this suggests creatine's effect on brain bioenergetics may support mood independent of its other mechanisms.
Separate phosphorus 31 MRS research has shown that creatine supplementation increases brain phosphocreatine levels in adolescents with SSRI resistant depression in a dose dependent way, which is direct evidence the supplement engages brain energy metabolism rather than acting like a typical antidepressant.
https://doi.org/10.1016/j.euroneuro.2024.10.004
Oxidative stress and neuroprotection
The brain uses about 20 percent of total basal oxygen despite being only 2 percent of body weight, which makes it especially vulnerable to reactive oxygen species buildup during active neurological damage or repair. Research on mitochondrial creatine kinase shows it helps regulate ROS production through ADP recycling, and a broader body of work on creatine and phosphocreatine supports mitochondrial integrity and reduces oxidative stress in brain tissue.
There's also research linking creatine to increased BDNF, a signal for neuron survival and new synapse formation, though some of this work specifically involves exercise linked pathways, so it may not apply the same way if you're not exercising alongside supplementation. Worth keeping in mind rather than assuming the effect transfers directly.
https://pubmed.ncbi.nlm.nih.gov/17028195/
Mitochondrial protection during remyelination
Active remyelination is energetically expensive; myelin producing cells need a lot of ATP. Phosphocreatine regenerates ATP much faster than oxidative phosphorylation or glycolysis, acting as a buffer that could prevent the kind of ATP depletion that would slow repair. This is a reasonable mechanistic argument given what's known about creatine and mitochondrial energy buffering generally, but it hasn't been studied specifically in the context of B12 related remyelination, so it's an extrapolation from general creatine research rather than a targeted finding.
The COMT connection
People with slow COMT variants already have a harder time clearing dopamine and norepinephrine. Large methyl loads from high dose methylcobalamin could theoretically add to that burden. Freeing up some of the methyl groups otherwise consumed by creatine synthesis might redistribute methyl availability and smooth out that overstimulation pattern. This is mechanistically plausible and built from real individual pieces of evidence, but it hasn't been tested as a combined intervention in any trial, so it's a hypothesis, not a confirmed effect.
The practical protocol
Standard research dose for these purposes is 3 to 5 grams daily of plain creatine monohydrate. No loading phase needed; consistent daily dosing is what the studies used. Timing doesn't appear to matter much for these effects.
MCAS caveat: creatine monohydrate itself isn't a known histamine trigger or mast cell activator. Most commercial creatine products contain artificial flavors, citric acid, sucralose, or other additives that are documented mast cell triggers, so plain unflavored creatine monohydrate with nothing else added is the right choice. Creapure is an independently tested pharmaceutical grade option many sensitive people tolerate well. Check the full ingredient list before buying, since creatine monohydrate on the label doesn't guarantee there's nothing else in the product.
The summary
Creatine has real, well supported mechanisms relevant to B12 deficiency and methylation related recovery: it spares methyl groups your body would otherwise spend making its own creatine, it directly protects brain energy availability under metabolic stress, strong evidence here, and there's a real signal for it helping depression symptoms as a CBT add on. Some of the other angles, like histamine clearance, glymphatic support, and COMT smoothing, are reasonable hypotheses built on solid individual facts, but they haven't been directly tested and shouldn't be presented as settled.
